N/A
Completed N=2,026
Electronic Tools to Increase Recognition and Improve Primary Care Management for Hypertension in Chronic Kidney Disease
Chronic Kidney Diseases · Hypertension
Source: ClinicalTrials.gov NCT03679247 ↗
Enrolled (actual)
2,026
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcomePrimary: Change in Systolic Blood Pressure (SBP) From Baseline to 180 Days — 14.6; 11.7 mmHg
Summary
In this project the investigators will create computer reminders through user-centered design and will validate the logic using retrospective electronic health record (EHR) data. Then the investigators will test the reminders in primary care clinics to see if they improve treatment of high blood pressure in early chronic kidney disease.
Hypothesis: The mean systolic blood pressure of the chronic kidney disease (CKD) population can be decreased by an intervention with three innovative features: 1) methods to synthesize EHR data in order to identify under-diagnosed chronic conditions, 2) iterative improvement in clinical decision support (CDS) content through human factors methods to maximize the "informativeness" of the CDS, and 3) the use of behavioral economic principles to create behavioral "nudges" internal and external to the CDS.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Systolic Blood Pressure (SBP) From Baseline to 180 Days |
14.6; 11.7 | — |
Eligibility Criteria
Patients meeting inclusion criteria below will be enrolled.
Inclusion Criteria
- 18 years or older
- Has visit with PCP at one of the intervention practices during the 2 years before the study period
- Chronic Kidney Disease, defined as two prior estimated glomerular filtration rate (eGFR) 16-59 mL/min/1.73m2 separated by 90 days (as calculated by CKD-EPI) or two prior urine albumin to creatinine ratio (UACR) >30 mg/g separated by 90 days
Exclusion Criteria
- Patients receiving care from residents in training
- Patients receiving care from physicians only seeing urgent care and walk-in patients
- Patients with a most recent eGFR ≤ 20 or two previous eGFRs within 2 years separated by at least 90 days ≤ 15
Data sourced from ClinicalTrials.gov (NCT03679247). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.